Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552955 · ClinicalTrials.gov registry record
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
A clinical trial of Lymphangioleiomyomatosis and Tuberous Sclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT00552955: Completed study of Lymphangioleiomyomatosis and Tuberous Sclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00552955 is a study of Lymphangioleiomyomatosis and Tuberous Sclerosis that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 35 participants, below the 827-participant average among 10 other Lymphangioleiomyomatosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00552955, a study of Lymphangioleiomyomatosis and Tuberous Sclerosis, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effect of fasting on lymphangioleiomyomas abdominal tumors formed from enlarged lymph nodes containing lymphatic fluid. Previous studies have determined that these tumors increase in size in the evening, but this result could stem from the fact that previous study participants were tested after eating lunch. The purpose of the study is to help researchers understand the factors that produce changes in size of lymphangioleiomyomas, as well as to improve the ability of medical professionals to diagnose lymphangioleiomyomas and avoid confusing these tumors with other malignant tumors. Volunteers must be women who are at least 18 years of age and who have been diagnosed with lymphangioleiomyomas in the abdominal or pelvic areas. Candidates who have had lung or kidney transplants or who have type 1 diabetes will be excluded. Candidates will be screened with a physical examination and medical history. During the study, participants will be admitted to a National Institutes of Health clinical center for three days to undergo a number of tests. Tests will include routine blood and urine tests, and electrocardiogram, research blood testing, and abdominal and pelvic ultrasounds....
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-10-26 |
| Est. Completion | 2016-03-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00552955
The ClinicalTrials.gov registry entry for NCT00552955 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 827-participant average among 10 other Lymphangioleiomyomatosis trials with a reported enrollment target (96% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Lymphangioleiomyomatosis appearing as the primary indexed condition, and to 0 interventions.
NCT00552955 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00552955 about?
NCT00552955 is a clinical study titled "Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women". This study will examine the effect of fasting on lymphangioleiomyomas abdominal tumors formed from enlarged lymph nodes containing lymphatic fluid. Previous studies have determined that these tumors increase in size in the evening, but this result could stem from the fact that previous study partici...
What is the current status of trial NCT00552955?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2007-10-26. Estimated completion is 2016-03-21.
What conditions does trial NCT00552955 study?
This clinical trial studies the following conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis, Lymphangioleiomyomas.
Who is sponsoring clinical trial NCT00552955?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00552955 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphangioleiomyomatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
RECRUITING · Phase 1
-
Safety and Durability of Sirolimus for Treatment of LAM
RECRUITING
-
TSC Biosample Repository and Natural History Database
RECRUITING
-
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
RECRUITING
-
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
RECRUITING · Phase 1
-
Study of the Disease Process of Lymphangioleiomyomatosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001442 · 35 participants · Phase 1
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
- NCT00001816 · 35 participants
The Impact of Starbright World on Children Being Treated at the NIH
- NCT00002578 · 35 participants · Phase 2
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
- NCT00003449 · 35 participants · Phase 2
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
Similar registry start date
- NCT05684068 · started 2028-08 · NA
Dimensional Changes: Randomized Clinical Trial
- NCT07167953 · started 2028-08 · NA
The Spiral MRI Study
- NCT07215013 · started 2028-07 · NA
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
- NCT07443332 · started 2028-07 · NA
Culturally Adapted Contingency Management
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.